Lei Shan S - OmicsDI

Show results for

Unknown (50)
Proteomics (11)
Metabolomics (3)
Genomics (1)

Organisms

Homo sapiens (9)
Mus musculus (2)
Macaca fascicularis fascicularis (1)

Repository

iProX (11)
MetaboLights (3)
EGA (1)

Technology Type

Mass spectrometry (3)

Instrument Platform

Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2023 (4)
2025 (3)
2024 (3)
2022 (2)
2026 (1)
2019 (1)

CHEBI ID

CHEBI:15428 (2)
CHEBI:15674 (2)
CHEBI:16344 (2)
CHEBI:16708 (2)
CHEBI:16750 (2)
CHEBI:18257 (2)
CHEBI:28747 (2)
CHEBI:37024 (2)
CHEBI:10072 (1)
CHEBI:116314 (1)
CHEBI:12962 (1)
CHEBI:131429 (1)
CHEBI:131887 (1)
CHEBI:132541 (1)
CHEBI:132542 (1)
CHEBI:132543 (1)
CHEBI:132558 (1)
CHEBI:132586 (1)
CHEBI:132588 (1)
CHEBI:132590 (1)
CHEBI:132983 (1)
CHEBI:134028 (1)
CHEBI:134287 (1)
CHEBI:136141 (1)
CHEBI:137259 (1)
CHEBI:138560 (1)
CHEBI:139325 (1)
CHEBI:140960 (1)
CHEBI:140964 (1)
CHEBI:142219 (1)

Metabolite Name

Glycine (2)
Guanosine (2)
Mannitol (2)
Palmitic acid (2)
Pyroglutamic acid (2)
Uric acid (2)
(+)-Prosopinine (1)
(+/-)-Bocconarborine A (1)
(+/-)-Bocconarborine B (1)
(1-((1-Methylpiperidin-2-yl)methyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (1)
(1-hexyl-5-phenyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone (1)
(10)-Gingerol (1)
(1R,12S,16Z,24E,26E,28Z,32S)-1,18-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0,]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1R,16Z,24E,26E,28Z)-1,18-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)propan-2-yl]-29-(hydroxymethyl)-19,30-dimethoxy-15,17,21,23,35-pentamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0,]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1R,2R,5Z,12R,13S,16Z)-25-(9H-pyrido[3,4-b]indol-1-yl)-11,22-diazapentacyclo[11.11.2.12,22.02,12.04,11]heptacosa-5,16,25-trien-13-ol (1)
(1R,2S,13S,16S,17S,19R,20R,22S,25S,27S)-1,2,24,24-tetramethyl-8,9-bis(3-methylbut-2-enyl)-22-(2-methylprop-1-enyl)-18,21,23,26-tetraoxa-4-azaoctacyclo[14.13.0.02,13.03,11.05,10.017,19.017,27.020,25]nonacosa-3(11),5(10),6,8-tetraen-16-ol (1)
(1R,2S,4S,6R,7S,8R,9S,12S,13S,18S)-6-methoxy-7,9,13-trimethyl-6-[(3S)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosan-16-one (1)
(1R,3S,6S,7E,13S,16R,17R,21S,22S)-17-[(2R,4R,5S,6R)-5-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-28-hydroxy-3,22-dimethyl-23,26-dioxo-24,27-dioxapentacyclo[23.2.1.01,6.013,22.016,21]octacosa-4,7,14,25(28)-tetraene-4-carboxylic acid (1)
(1S,2R,4aR,6aS,6bR,12aS,12bR,14bR)-1,2,4a,6a,6b,9,12a-Heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,11,12,12a,12b,13,14b-octadecahydropicene (1)
(1S,2S,6R,7S,9R,10R,11R)-1,4,4-trimethyl-8,13-dioxatetracyclo[8.2.1.02,6.07,11]tridecane-9,10-diol (1)
(1S,3R)-5-[3-[4-[(1S,3R)-6,8-dihydroxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-5-yl]-1-hydroxy-8-methoxy-6-methylnaphthalen-2-yl]-4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl]-1,3-dimethyl-1,2,3,4-tetrahydroisoquinoline-6,8-diol (1)
(1S,3Z,5R,7R)-3-[(3,4-dihydroxyphenyl)-hydroxy-methylene]-1-[(2S)-2-isopropenyl-5-methyl-hex-4-enyl]-6,6-dimethyl-5,7-bis(3-methylbut-2-enyl)bicyclo[3.3.1]nonane-2,4,9-trione (1)
(1S,4R)-1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione (1)
(1aR,7aS,10aS,10bS)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one (1)
(2-Chloro-benzyl)-pyridin-3-ylmethyl-amine (1)
(2-Iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone (1)
(2-methoxy-4-{2-[(1R,16Z,24E,26E,28Z)-1,18,19-trihydroxy-30-methoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0,]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl}cyclohexyl)oxidanesulfonic acid (1)
(2-{[3-(3,4-Dihydroxy-5-methoxyphenyl)prop-2-enoyl]oxy}ethyl)trimethylazanium (1)
(23S)-23,25,26-trihydroxycalciol (1)
(25S)-26-Hydroxy-24-methylenecycloartan-3-one (1)

Release Date

2024 (9)
2022 (7)
2020 (6)
2025 (5)
2021 (5)
2019 (4)
2017 (4)
2016 (4)
2023 (3)
2026 (1)
2018 (1)
2015 (1)

Previous page
1 / 7
You're on page 1
page 2
page 3
page 4
page 5
page 6
page 7
Next page

Sort by:

Relevance

Page size

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis.

Not available

S-EPMC6350390 | biostudies-literature

S-propargyl-cysteine promotes the stability of atherosclerotic plaque via maintaining vascular muscle contractile phenotype.

Not available

S-EPMC10847265 | biostudies-literature

The Effects of Endoplasmic-Reticulum-Resident Selenoproteins in a Nonalcoholic Fatty Liver Disease Pig Model Induced by a High-Fat Diet.

Not available

S-EPMC7146353 | biostudies-literature

Effects of Dietary Selenium Deficiency or Excess on Selenoprotein Gene Expression in the Spleen Tissue of Pigs.

Not available

S-EPMC6940954 | biostudies-literature

The intra-neuroendoscopic technique (INET): a modified minimally invasive technique for evacuation of brain parenchyma hematomas.

Not available

S-EPMC6503359 | biostudies-literature

Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome

INTRODUCTION: Neonatal cholestatic disorders are a group of hepatobiliary diseases occurring in the first 3 months of life. The most common causes of neonatal cholestasis are infantile hepatitis syndrome (IHS) and biliary atresia (BA). The clinical manifestations of the two diseases are ...

2019-06-25 | MTBLS689 | MetaboLights

Psychological stress exacerbates vitiligo via dysregulated proteolysis of substance P and MRGPRX2-dependent mast cell activation

Although psychological stress has been anecdotally related to flare-ups of vitiligo, the underlying mechanism(s) has remained poorly defined. In this study, we investigated whether substance P (SP) and its proteolytic fragments (SP1-9 and SP1-7) modulate the anti-melanocyte immune response under str...

ORGANISM(S): Homo Sapiens

2025-11-07 | PXD070437 |

PPARγ Regulates Triclosan Induced Placental Dysfunction.

Not available

S-EPMC8750171 | biostudies-literature

Age-, sex- and proximal-distal-resolved multi-omics identifies regulators of intestinal aging in non-human primates.

The incidence of intestinal diseases increases with age, but the regulators of gut aging and the molecules linking gut aging and diseases remain largely unknown. By profiling the transcriptome, proteome, phosphoproteome and metabolome of 104 Macaca fascicularis large intestinal tissues, ...

2023-12-14 | MTBLS7612 | MetaboLights

Distinct prognostic values of S100 mRNA expression in breast cancer.

Not available

S-EPMC5209742 | biostudies-literature

Previous page
1 / 7
You're on page 1
page 2
page 3
page 4
page 5
page 6
page 7
Next page

Sort by:

Relevance

Page size

65 Results

Show results for

Organisms

Repository

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets